New cervical cancer treatment reduces death risk by 40%: Lancet study

Posted on:
Key Points

A new treatment plan for cervical cancer has shown a 40% reduction in the risk of death, offering hope for improved survival rates, as per a Lancet study..

With 6,60,000 new cases and 3,50,000 deaths due to cervical cancer reported in 2022, the researchers revealed that his short-term treatment plan could improve survival of patients with locally advanced cervical cancer...

The treatment for locally advanced cervical cancer is usually a combination of chemotherapy and radiation, but many patients still experience the cancer spreading and don't survive...

"This short-course induction chemotherapy regimen followed within 7 days by chemoradiotherapy improves survival of patients with locally advanced cervical cancer..

It should now be considered a standard of care and be included in the design of future trials that explore the incorporation of new agents for the treatment of locally advanced cervical cancer," the authors of the study wrote...